BL
BioLineRx Ltd.
BLRX.TA · TLV
1.40 ILA +7.69% (+0.10 ILA)
1M -13.33%
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 29.00%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
Asset turnover N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Debt/Assets N/A
Stability
37 /100
Moderate Beta 0.71x
EPS volatility 130.13%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BLRX.TA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Philip A. Serlin
Employees
22
Headquarters
Hevel Modi'in
Evenimente viitoare
18 NOV.
Earnings
Upcoming earnings report